← back to search

Yungan Tao

Institut Gustave Roussy · FR
Area of research
Otorhinolaryngology · Surgery
Research interest
Research interests include Head and Neck Cancer Studies, Head and Neck Surgical Oncology, Esophageal Cancer Research and Treatment, and Oral health in cancer treatment.
h-index
40
citations
5,462
works
178
NIH funding
primary concept
Medicine
email

Recent publications

International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)
International Journal of Radiation Oncology*Biology*Physics 2025cited by 12position: middledoi
Consensus for a postoperative atlas of sinonasal substructures from a modified Delphi study to guide radiotherapy in sinonasal malignancies
Radiotherapy and Oncology 2025cited by 7position: middledoi
A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)
Radiotherapy and Oncology 2024cited by 18position: middledoi
International Recommendations on Reirradiation by Intensity Modulated Radiation Therapy for Locally Recurrent Nasopharyngeal Carcinoma
International Journal of Radiation Oncology*Biology*Physics 2021cited by 98position: middledoi
A Phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma
Radiotherapy and Oncology 2021cited by 24position: middledoi
Response to comments HN-20-1003 "Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma: useful treatment option with a caveat".
2020cited by 0position: contributordoi
Optimal sequencing of chemotherapy with chemoradiotherapy based on TNM stage classification and EBV DNA in locoregionally advanced nasopharyngeal carcinoma
Cancer Communications 2019cited by 27position: middledoi
International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma
Radiotherapy and Oncology 2017cited by 372position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

C. Rasch · Delft University of Technology1 papers (2024–2024) · 1 papers (2021–2021)Ann Hoeben · VIB-KU Leuven Center for Microbiology1 papers (2024–2024) · 1 papers (2021–2021)Cai Grau · Aarhus University Hospital1 papers (2017–2017)Nancy Y. Lee · Soonchunhyang University Hospital Seoul1 papers (2017–2017)Roel J.H.M. Steenbakkers · University Medical Center Groningen1 papers (2024–2024)Lin‐Quan Tang · Sun Yat-sen University1 papers (2019–2019) · 1 papers (2021–2021)Sergi Benavente · Vall d'Hebron Institute of Oncology1 papers (2024–2024)Kevin J. Harrington · NIHR Biomedical Research Centre at The Royal Marsden and the ICR1 papers (2017–2017) · 1 papers (2024–2024)Melvin L.K. Chua · National Cancer Centre Singapore1 papers (2019–2019) · 1 papers (2024–2024)Sue S. Yom · UCSF Helen Diller Family Comprehensive Cancer Center1 papers (2017–2017)Sharon Shuxian Poh · National University of Singapore1 papers (2017–2017) · 1 papers (2024–2024)Vincent Grégoire · Institut d’Hématologie et d’Oncologie Pédiatrique1 papers (2017–2017)Yong Chan Ahn · Samsung Medical Center1 papers (2017–2017) · 1 papers (2024–2024)